JENNIFER ILLIG: Open Payments
NPI 1245335660 · STATE COLLEGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,081 in 56 payments from 15 companies in 2025. Trend: 2023 $410 · 2024 $912 · 2025 $1,081
Food & beverage: $1,081
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $216 |
| Alnylam Pharmaceuticals Inc. | 6 | $179 |
| SCPHARMACEUTICALS INC. | 7 | $163 |
| E.R. Squibb & Sons, L.L.C. | 7 | $141 |
| PFIZER INC. | 5 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Amgen Inc. | 4 | $62 |
| Novo Nordisk Inc | 2 | $44 |
| WATERMARK MEDICAL, INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $25 |
Products named: LEQVIO, FUROSCIX, CAMZYOS, ELIQUIS, AMVUTTRA, ONPATTRO, JARDIANCE, REPATHA.
Industry payments across PA — which companies pay providers there.
